from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1138c/-

LFCtreatmentdescriptionclass of inhibitor

-0.140

Amikacinug/mL Amikacintranslation

-0.984

Cap5-10ug/mL Capreomycintranslation

-0.996

Rox10-50 ug/mL Roxithromycintranslation

0.437

SM2-5 ug/mL Streptomycintranslation

-1.044

Tet5-10 ug/mL Tetracyclinetranslation

0.429

Rif0.2-5ug/mL Rifampicintranscription

-0.339

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.346

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.431

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.546

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.507

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.116

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.019

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.130

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.380

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.338

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.911

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.319

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.210

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.681

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.244

KCN5-20 ug/mL Potassium cyaniderespiration

-0.112

NaN30.2-2 mM Sodium aziderespiration

-1.166

Nigericin50 uM Nigericinrespiration

-0.537

TRC10-150 ug/mL Triclosanrespiration

0.932

TRZ10-25 ug/mL Thioridazinerespiration

-1.334

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.187

menadione6-10 ug/mL Menadionerespiration

-0.356

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.362

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.441

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.224

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.820

NRP_1Non-replicating persistence stage 1dosRassociated

0.615

Amp0.2mg/mL AmpicillincellWall

0.080

Cephalexin20-100 ug/mL CephalexincellWall

-0.634

Cerulenin0.32-5 ug/mL CerulenincellWall

0.209

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.365

EMB10-20 ug/mL EthambutolcellWall

-0.138

Eta12-40 ug/mL EthionamidecellWall

-0.506

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.197

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.706

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.620

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.476

BZA0.12 mg/mL BenzamidearomaticAmides

0.495

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.464

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.662

H2O24 mM hydrogen peroxideDNAdamaging

-0.054

Levo10 ug/mL LevofloxacinDNAdamaging

0.905

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.156

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.175

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.355

UVUV-irradiationDNAdamaging

0.257

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.529

Antimycin12.5-50 ug/mL Antimycin A?

-0.266

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.525

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.672

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.062

PA8240.2-2 ug/mL PA-824?

-1.119

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.553

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.768

Verapamil50 uM Verapamil?

-0.455

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.403

methoxatin10-20 ug/mL Methoxatin?